These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3479708)
1. [Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary]. Gadducci A; Bartolini T; Ferdeghini M; Facchini V; Bianchi R; Fioretti P Minerva Ginecol; 1987 Sep; 39(9):601-6. PubMed ID: 3479708 [No Abstract] [Full Text] [Related]
2. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers]. Kataoka A; Yakushiji M Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782 [TBL] [Abstract][Full Text] [Related]
3. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients]. Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923 [TBL] [Abstract][Full Text] [Related]
4. [Significance of tumor markers in the treatment of patients with ovarian malignancies]. Tomoda Y; Kano T; Furuhashi Y; Mizuno K; Kamiya N; Mizuno K; Sakakibara K; Ohta M Gan To Kagaku Ryoho; 1987 Nov; 14(11):3027-33. PubMed ID: 2445293 [TBL] [Abstract][Full Text] [Related]
5. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor. Tamakoshi K; Kikkawa F; Shibata K; Tomoda K; Obata NH; Wakahara F; Tokuhashi Y; Ishikawa H; Kawai M; Tomoda Y Gynecol Oncol; 1996 Jul; 62(1):67-72. PubMed ID: 8690294 [TBL] [Abstract][Full Text] [Related]
6. Roles of CA125 in patients with ovarian cancer--usefulness in periodical monitoring. Kawai M; Inagaki S; Yamashita H; Imaizumi H; Kakihara M; Arii Y Nihon Gan Chiryo Gakkai Shi; 1988 May; 23(5):1059-67. PubMed ID: 3166484 [No Abstract] [Full Text] [Related]
7. Preliminary results on the use of Ca 15-3 in malignant ovarian pathology. Ferdeghini M; Gadducci A; Romagnoli S; Bartolini T; Facchini V; Scatena P; Bianchi R; Fioretti P J Nucl Med Allied Sci; 1987; 31(4):299-302. PubMed ID: 3481812 [No Abstract] [Full Text] [Related]
8. Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection. Erkanli A; Taylor DD; Dean D; Eksir F; Egger D; Geyer J; Nelson BH; Stone B; Fritsche HA; Roden RB Cancer Res; 2006 Feb; 66(3):1792-8. PubMed ID: 16452240 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of serum determinations of CA125, CA15-3 and CA50 in the preoperative evaluation of adnexal tumors]. Gadducci A; Facchini V; Ferdeghini M; Ceccarini T; Bartolini T; Fontana V; Bianchi R; Fioretti P Ann Ostet Ginecol Med Perinat; 1988; 109(4):199-204. PubMed ID: 3232907 [No Abstract] [Full Text] [Related]
10. [The clinical usefulness of the measurement of serum sialyl SSEA-1 antigen levels in patients with gynecologic diseases: as respects the comparative effectiveness of sialyl SSEA-1 and CA125]. Kobayashi H Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):828-34. PubMed ID: 3166483 [TBL] [Abstract][Full Text] [Related]
12. Significant increases in serum CA125 and CA19-9 following torsion from an adenofibroma of the ovary: a case report. Fujiwara K; Moriya T; Mikami Y; Hiratsuka J; Sawada S; Imajo Y; Kohno I Jpn J Clin Oncol; 1994 Apr; 24(2):116-9. PubMed ID: 8158859 [TBL] [Abstract][Full Text] [Related]
13. [Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer]. Gadducci A; Ferdeghini M; Bartolini T; Facchini V; Bianchi R; Fioretti P Ann Ostet Ginecol Med Perinat; 1986; 107(4):193-9. PubMed ID: 3467641 [No Abstract] [Full Text] [Related]
14. [Evaluation of tumor marker in ovarian dermoid cyst]. Mikuni M; Makinoda S; Tanaka T; Okuda T; Domon H; Fujimoto S Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):479-84. PubMed ID: 2373920 [TBL] [Abstract][Full Text] [Related]
15. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers]. Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666 [TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors]. Suzuki M; Sekiguchi I; Tamada T; Sakurabayashi I; Kawai T Rinsho Byori; 1985 Feb; 33(2):173-7. PubMed ID: 3858562 [No Abstract] [Full Text] [Related]
18. Extremely high levels of CA19-9 and CA125 antigen in benign mucinous ovarian cystadenoma. Ye C; Ito K; Komatsu Y; Takagi H Gynecol Oncol; 1994 Feb; 52(2):267-71. PubMed ID: 7508878 [TBL] [Abstract][Full Text] [Related]
19. [Biological markers in cancer of the ovary]. Valladares Y Rev Esp Oncol; 1985; 32(2):363-73. PubMed ID: 3843467 [TBL] [Abstract][Full Text] [Related]
20. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Lai IR; Lee WJ; Huang MT; Lin HH Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]